Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.
You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.
Other companies in Regenxbio’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR) and Altimmune (NASDAQ:ALT).
Regenxbio has a consensus price target of $42.07.
The stock price for Regenxbio (NASDAQ: RGNX) is $8.59 last updated October 31, 2024 at 6:08 PM EDT.
There are no upcoming dividends for Regenxbio.
Regenxbio’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Regenxbio.
Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.